11-17470182-C-T

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong

The NM_000352.6(ABCC8):​c.331G>A​(p.Gly111Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G111E) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

ABCC8
NM_000352.6 missense

Scores

7
4
8

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 1.19
Variant links:
Genes affected
ABCC8 (HGNC:59): (ATP binding cassette subfamily C member 8) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions as a modulator of ATP-sensitive potassium channels and insulin release. Mutations in the ABCC8 gene and deficiencies in the encoded protein have been observed in patients with hyperinsulinemic hypoglycemia of infancy, an autosomal recessive disorder of unregulated and high insulin secretion. Mutations have also been associated with non-insulin-dependent diabetes mellitus type II, an autosomal dominant disease of defective insulin secretion. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PM1
In a helix (size 20) in uniprot entity ABCC8_HUMAN there are 6 pathogenic changes around while only 0 benign (100%) in NM_000352.6
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-17470181-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1500046.Status of the report is criteria_provided_single_submitter, 1 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.958
PP5
Variant 11-17470182-C-T is Pathogenic according to our data. Variant chr11-17470182-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 210074.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-17470182-C-T is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ABCC8NM_000352.6 linkuse as main transcriptc.331G>A p.Gly111Arg missense_variant 3/39 ENST00000389817.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ABCC8ENST00000389817.8 linkuse as main transcriptc.331G>A p.Gly111Arg missense_variant 3/391 NM_000352.6 P4Q09428-1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152146
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000796
AC:
2
AN:
251372
Hom.:
0
AF XY:
0.00000736
AC XY:
1
AN XY:
135890
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000479
AC:
7
AN:
1461880
Hom.:
0
Cov.:
32
AF XY:
0.00000275
AC XY:
2
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000360
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152146
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74304
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hyperinsulinemic hypoglycemia, familial, 1 Pathogenic:5
Pathogenic, criteria provided, single submitterclinical testingNeuberg Centre For Genomic Medicine, NCGM-- -
Pathogenic, criteria provided, single submittercurationBroad Center for Mendelian Genomics, Broad Institute of MIT and HarvardAug 16, 2023The p.Gly111Arg variant in ABCC8 has been reported in >10 individuals with hyperinsulinemic hypoglycemia (PMID: 15579781, 15466080, 20943781, 23652837, 23345197, 25117148, 25201519, 25972930), and has been identified in 0.003% (1/30612) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs761749884). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 210074) and has been interpreted as pathogenic by Invitae, Women's Health and Genetics/Laboratory Corporation of America (LabCorp), and Genetic Services Laboratory (University of Chicago) and as likely pathogenic by Counsyl and Molecular Genetics (Madras Diabetes Research Foundation). Of the many affected individuals, at least 3 were compound heterozygotes that carried a reported pathogenic variant in trans, and at least 2 were homozygotes, which increases the likelihood that the p.Gly111Arg variant is pathogenic (Variation ID: 551999; PMID: 23652837, 15466080, 23345197, 15579781, 20943781). In vitro functional studies provide some evidence that the p.Gly111Arg variant may slightly impact protein function (PMID: 15579781). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive hyperinsulinemic hypoglycemia. ACMG/AMP Criteria applied: PM3_very_strong, PM2_supporting, PS3_supporting (Richards 2015). -
Likely pathogenic, criteria provided, single submitterclinical testingMolecular Genetics, Madras Diabetes Research Foundation-- -
Pathogenic, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJun 16, 2015- -
Likely pathogenic, criteria provided, single submitterclinical testingCounsylJun 07, 2016- -
Familial hyperinsulinism Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpDec 14, 2021Variant summary: ABCC8 c.331G>A (p.Gly111Arg) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251372 control chromosomes. c.331G>A has been reported in the literature in multiple individuals affected with Congenital Hyperinsulinism (Kapoor_2013, Wang_2017). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Type 2 diabetes mellitus Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsSep 26, 2023- -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeDec 30, 2023This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 111 of the ABCC8 protein (p.Gly111Arg). This variant is present in population databases (rs761749884, gnomAD 0.003%). This missense change has been observed in individuals with autosomal recessive familial hyperinsulinism (PMID: 20943781, 21992908, 23345197, 23652837, 25117148, 25201519, 30352420). ClinVar contains an entry for this variant (Variation ID: 210074). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ABCC8 protein function. Experimental studies have shown that this missense change affects ABCC8 function (PMID: 15579781, 27573238). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.93
BayesDel_addAF
Pathogenic
0.36
D
BayesDel_noAF
Pathogenic
0.37
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.48
.;.;T;.;.;.;.;.
Eigen
Benign
0.14
Eigen_PC
Benign
0.12
FATHMM_MKL
Benign
0.30
N
LIST_S2
Uncertain
0.96
D;.;D;D;D;D;D;D
M_CAP
Pathogenic
0.70
D
MetaRNN
Pathogenic
0.96
D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
0.80
D
MutationAssessor
Benign
1.6
.;L;L;L;.;.;.;.
MutationTaster
Benign
0.58
N;N
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-0.88
.;.;N;N;.;.;.;.
REVEL
Uncertain
0.64
Sift
Benign
0.032
.;.;D;D;.;.;.;.
Sift4G
Benign
0.093
.;.;T;T;.;.;.;.
Polyphen
0.98
.;.;D;.;.;.;.;.
Vest4
0.89, 0.89
MutPred
0.91
Gain of methylation at G111 (P = 0.0066);Gain of methylation at G111 (P = 0.0066);Gain of methylation at G111 (P = 0.0066);Gain of methylation at G111 (P = 0.0066);Gain of methylation at G111 (P = 0.0066);Gain of methylation at G111 (P = 0.0066);Gain of methylation at G111 (P = 0.0066);Gain of methylation at G111 (P = 0.0066);
MVP
0.90
MPC
0.65
ClinPred
0.89
D
GERP RS
4.9
Varity_R
0.55
gMVP
0.91

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs761749884; hg19: chr11-17491729; API